Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glecaprevir + pibrentasvir in hemodialysis patients with chronic hepatitis C
jRCTs031200042Completed
- Sponsor
- Chiba University Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of glecaprevir + pibrentasvir in chronic hepatitis C (CHC), sponsored by Chiba University Hospital. Primary endpoint: Incident rate of drug-related adverse events. Started Jan 2021; status: completed.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on jRCTs031200042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200042.